Skip to content

A Randomized Controlled Trial of Advanced Colorectal Cancer with Fuzheng Jiedu Prescription Combined with Chemotherapy

A Randomized Controlled Trial of Advanced Colorectal Cancer with Fuzheng Jiedu Prescription Combined with Chemotherapy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000038964
Enrollment
Unknown
Registered
2020-10-10
Start date
2020-03-01
Completion date
Unknown
Last updated
2021-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clolrectal cancer

Interventions

Sponsors

Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients meeting the above diagnostic criteria; Two Patients with stage IV colorectal cancer according to TNM stage; X-ray, CT, CEA value and other tumor observation indicators available for observation: there is at least one evaluable lesion (measurable or unmeasurable lesion), if the lesion that has received local treatment (radiotherapy, ablation, vascular intervention, etc.) is the only lesion, then the lesion must have imaging basis for clear disease progression; the occurrence of the same disease Temporal metastasis; 3. For patients with Karnofsky score >= 60, ECoG score <= 1; 4. Patients over 18 years old; 5. Patients with an expected survival period of more than 3 months; 6. Patients who voluntarily participated in this study were followed up with informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe infection; 2. Patients with severe hypertension, coronary heart disease, cardiac insufficiency, liver and kidney or marrow dysfunction; 3. Women with history of mental illness or pregnancy; 4. Patients who have participated in clinical trials of other drugs or medical devices in recent one month.

Design outcomes

Primary

MeasureTime frame
PFS;

Countries

China

Contacts

Public ContactGuoliang Yan

Municipal Hospital of Traditional Chinese Medicine,Shanghai University of Traditional Chinese Medicine

13761788439@139.com+86 18116070928

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026